Melcap Systems

Company Overview

Snapshot

Founded in November 2011 by Boris Voznesensky and Rami Eliakim, Melcap Systems operated with 1–10 employees. The company secured funding across two rounds. A significant milestone was the investment from Roman Abramovich in December 2015.

Business overview

Melcap Systems developed a noninvasive system for treating obesity, utilizing a disposable and ingestible stimulating capsule with variable volume. This capsule can be wirelessly guided and fixed in the gastrointestinal tract using a magnetic system. The company's core technology aims to address the global obesity epidemic by providing a non-surgical treatment option, primarily serving patients in the Health Tech & Life Sciences sector, specifically within Digital Therapeutics and Digital Healthcare.

Strategic signal

Melcap Systems ceased operations in December 2022, indicating a significant strategic shift from its initial mission to combat the global obesity epidemic with its noninvasive treatment system. This cessation signals to investors and innovation teams a discontinuation of its product development and market presence in the digital therapeutics space.

Company Intelligence Q&A

What is the primary focus of Melcap Systems?

Melcap Systems focuses on developing a noninvasive system for treating overweight and obesity, utilizing an ingestible, wirelessly guided stimulating capsule.

When was Melcap Systems founded?

Melcap Systems was founded in November 2011.

Who are the co-founders of Melcap Systems?

Boris Voznesensky and Rami Eliakim are the co-founders of Melcap Systems.

What was a notable investment received by Melcap Systems?

In December 2015, Melcap Systems received an investment from Roman Abramovich, which was reported to be $2 million.

What is the current operational status of Melcap Systems?

Melcap Systems is non-active and ceased to operate in December 2022.